These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35514162)

  • 1. Influence of CYP2D6 genetic variation on adverse events with propafenone in the pediatric and young adult population.
    Sunthankar SD; Kannankeril PJ; Gaedigk A; Radbill AE; Fish FA; Van Driest SL
    Clin Transl Sci; 2022 Jul; 15(7):1787-1795. PubMed ID: 35514162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of
    Doki K; Shirayama Y; Sekiguchi Y; Aonuma K; Kohda Y; Ieda M; Homma M
    Pharmacogenomics; 2020 Dec; 21(18):1279-1288. PubMed ID: 33203295
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessment of 25 CYP2D6 alleles found in the Chinese population on propafenone metabolism in vitro.
    Su Y; Liang BQ; Feng YL; Zhan Y; Gu E; Chen X; Dai DP; Hu GX; Cai JP
    Can J Physiol Pharmacol; 2016 Aug; 94(8):895-9. PubMed ID: 27203132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I.
    Zhou SF
    Clin Pharmacokinet; 2009; 48(11):689-723. PubMed ID: 19817501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of CYP2D6*10B genotype on pharmacokinetics of propafenone enantiomers in Chinese subjects.
    Chen B; Cai WM
    Acta Pharmacol Sin; 2003 Dec; 24(12):1277-80. PubMed ID: 14653957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP2D6 genotype and adverse events to risperidone in children and adolescents.
    Oshikoya KA; Neely KM; Carroll RJ; Aka IT; Maxwell-Horn AC; Roden DM; Van Driest SL
    Pediatr Res; 2019 Apr; 85(5):602-606. PubMed ID: 30661084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and pharmacodynamic interaction between mexiletine and propafenone in human beings.
    Labbé L; O'Hara G; Lefebvre M; Lessard E; Gilbert M; Adedoyin A; Champagne J; Hamelin B; Turgeon J
    Clin Pharmacol Ther; 2000 Jul; 68(1):44-57. PubMed ID: 10945315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined administration of quinidine and propafenone for atrial fibrillation: the CAQ-PAF study.
    O'Hara GE; Philippon F; Gilbert M; Champagne J; Michaud V; Charbonneau L; Pruneau G; Hamelin BA; Geelen P; Turgeon J
    J Clin Pharmacol; 2012 Feb; 52(2):171-9. PubMed ID: 21508180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition of propafenone in a poor metabolizer of CYP2D6 with Gilbert's syndrome.
    Dilger K; Meisel P; Hofmann U; Eichelbaum M
    Ther Drug Monit; 2000 Jun; 22(3):366-8. PubMed ID: 10850406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of CYP2D6*10 genotype on propafenone pharmacodynamics in Chinese patients with ventricular arrhythmia.
    Cai WM; Xu J; Chen B; Zhang FM; Huang YZ; Zhang YD
    Acta Pharmacol Sin; 2002 Nov; 23(11):1040-4. PubMed ID: 12421483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of CYP2D6 polymorphisms on the pharmacokinetics of propafenone and its two main metabolites.
    Rouini MR; Afshar M
    Therapie; 2017 Jun; 72(3):373-382. PubMed ID: 28087064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of CYP2D6 activity on the kinetics of propafenone enantiomers in Chinese subjects.
    Cai WM; Chen B; Cai MH; Chen Y; Zhang YD
    Br J Clin Pharmacol; 1999 May; 47(5):553-6. PubMed ID: 10336580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consequences of rifampicin treatment on propafenone disposition in extensive and poor metabolizers of CYP2D6.
    Dilger K; Greiner B; Fromm MF; Hofmann U; Kroemer HK; Eichelbaum M
    Pharmacogenetics; 1999 Oct; 9(5):551-9. PubMed ID: 10591535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacogenetic study of the response to flecainide and propafenone in patients with atrial fibrillation].
    Martínez-Sellés M; Castillo I; Montenegro P; Martín ML; Almendral J; Sanjurjo M
    Rev Esp Cardiol; 2005 Jun; 58(6):745-8. PubMed ID: 15970126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of CYP2D6 polymorphism on the antiarrhythmic efficacy of propafenone in patients with paroxysmal atrial fibrillation during 3 months propafenone prophylactic treatment.
    Jazwinska-Tarnawska E; Orzechowska-Juzwenko K; Niewinski P; Rzemislawska Z; Loboz-Grudzien K; Dmochowska-Perz M; Slawin J
    Int J Clin Pharmacol Ther; 2001 Jul; 39(7):288-92. PubMed ID: 11471772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the QTc interval after administration of flecainide acetate, with and without coadministered paroxetine, in relation to cytochrome P450 2D6 genotype: data from an open-label, two-period, single-sequence crossover study in healthy Korean male subjects.
    Lim KS; Jang IJ; Kim BH; Kim J; Jeon JY; Tae YM; Yi S; Eum S; Cho JY; Shin SG; Yu KS
    Clin Ther; 2010 Apr; 32(4):659-66. PubMed ID: 20435235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propafenone associated severe central nervous system and cardiovascular toxicity due to mirtazapine: a case of severe drug interaction.
    Rajpurohit N; Aryal SR; Khan MA; Stys AT; Stys TP
    S D Med; 2014 Apr; 67(4):137-9. PubMed ID: 24791374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regioselective hydroxylation of an antiarrhythmic drug, propafenone, mediated by rat liver cytochrome P450 2D2 differs from that catalyzed by human P450 2D6.
    Uehara S; Murayama N; Yamazaki H; Suemizu H
    Xenobiotica; 2019 Nov; 49(11):1323-1331. PubMed ID: 30596462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results and challenges of Cytochrome P450 2D6 (CYP2D6) testing in an ethnically diverse South Florida population.
    Salyakina D; Roy S; Wang W; Oliva M; Akhouri R; Sotto I; Mulas N; Solano R; Fernández JR; Sanchez S; Shamshad U; Perlyn C; McCafferty-Fernandez J
    Mol Genet Genomic Med; 2019 Sep; 7(9):e922. PubMed ID: 31389673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP2D6 phenotype determines pharmacokinetic variability of propafenone enantiomers in 16 HAN Chinese subjects.
    Cai WM; Chen B; Cai MH; Zhang YD
    Zhongguo Yao Li Xue Bao; 1999 Aug; 20(8):720-4. PubMed ID: 10678105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.